The aim of this study is the early (presymptomatic) detection of pregnancy complications, which could contribute to a preventive treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Optimizing and validating a non-invasive prenatal genetic screening for the early presymptomatic detection of pregnancy complications
Timeframe: Through study completion, an average of 30 weeks
Optimizing and validating a non-invasive prenatal genetic screening for the early presymptomatic detection of pregnancy complications
Timeframe: Through study completion, an average of 30 weeks